ONTEX GROUP NV (ONTEX.BR) Stock Fundamental Analysis
Europe - EBR:ONTEX - BE0974276082 - Common Stock
6.25 EUR
+0.07 (+1.13%)
We assign a fundamental rating of 3 out of 10 to ONTEX. ONTEX was compared to 13 industry peers in the Personal Care Products industry. Both the profitability and financial health of ONTEX have multiple concerns. ONTEX has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
ONTEX had positive earnings in the past year.
ONTEX had a positive operating cash flow in the past year.
In multiple years ONTEX reported negative net income over the last 5 years.
In the past 5 years ONTEX always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 0.44%, ONTEX is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 1.11%, ONTEX is doing worse than 71.43% of the companies in the same industry.
The Return On Invested Capital of ONTEX (6.78%) is worse than 71.43% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ONTEX is significantly below the industry average of 12.37%.
The last Return On Invested Capital (6.78%) for ONTEX is above the 3 year average (4.39%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.44% | ||
| ROE | 1.11% | ||
| ROIC | 6.78% |
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
1.3 Margins
ONTEX has a worse Profit Margin (0.55%) than 71.43% of its industry peers.
In the last couple of years the Profit Margin of ONTEX has declined.
ONTEX has a worse Operating Margin (7.98%) than 71.43% of its industry peers.
ONTEX's Operating Margin has improved in the last couple of years.
The Gross Margin of ONTEX (29.23%) is worse than 85.71% of its industry peers.
ONTEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.98% | ||
| PM (TTM) | 0.55% | ||
| GM | 29.23% |
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ONTEX is still creating some value.
ONTEX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ONTEX has more shares outstanding
The debt/assets ratio for ONTEX has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.28, we must say that ONTEX is in the distress zone and has some risk of bankruptcy.
ONTEX's Altman-Z score of 1.28 is on the low side compared to the rest of the industry. ONTEX is outperformed by 85.71% of its industry peers.
The Debt to FCF ratio of ONTEX is 6.97, which is on the high side as it means it would take ONTEX, 6.97 years of fcf income to pay off all of its debts.
ONTEX has a worse Debt to FCF ratio (6.97) than 64.29% of its industry peers.
ONTEX has a Debt/Equity ratio of 0.72. This is a neutral value indicating ONTEX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, ONTEX is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 6.97 | ||
| Altman-Z | 1.28 |
ROIC/WACC1.24
WACC5.47%
2.3 Liquidity
ONTEX has a Current Ratio of 1.21. This is a normal value and indicates that ONTEX is financially healthy and should not expect problems in meeting its short term obligations.
ONTEX has a Current ratio (1.21) which is in line with its industry peers.
A Quick Ratio of 0.81 indicates that ONTEX may have some problems paying its short term obligations.
ONTEX has a Quick ratio (0.81) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
ONTEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.09%.
Measured over the past years, ONTEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.62% on average per year.
ONTEX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.67%.
The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%
3.2 Future
The Earnings Per Share is expected to grow by 8.84% on average over the next years. This is quite good.
ONTEX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.97% yearly.
EPS Next Y-57.18%
EPS Next 2Y-2.66%
EPS Next 3Y0.8%
EPS Next 5Y8.84%
Revenue Next Year-2.14%
Revenue Next 2Y0.08%
Revenue Next 3Y0.85%
Revenue Next 5Y1.97%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 52.08, the valuation of ONTEX can be described as expensive.
Based on the Price/Earnings ratio, ONTEX is valued a bit more expensive than the industry average as 78.57% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of ONTEX to the average of the S&P500 Index (27.42), we can say ONTEX is valued expensively.
With a Price/Forward Earnings ratio of 13.34, ONTEX is valued correctly.
ONTEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. ONTEX is cheaper than 92.86% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ONTEX to the average of the S&P500 Index (22.94), we can say ONTEX is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.08 | ||
| Fwd PE | 13.34 |
4.2 Price Multiples
92.86% of the companies in the same industry are more expensive than ONTEX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ONTEX indicates a rather cheap valuation: ONTEX is cheaper than 92.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.98 | ||
| EV/EBITDA | 5.29 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.66%
EPS Next 3Y0.8%
5. Dividend
5.1 Amount
ONTEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EBR:ONTEX (10/17/2025, 7:00:00 PM)
6.25
+0.07 (+1.13%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners46.36%
Inst Owner ChangeN/A
Ins Owners3.06%
Ins Owner ChangeN/A
Market Cap514.69M
Analysts78.57
Price Target7.78 (24.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.35%
PT rev (3m)-20.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-53.26%
EPS NY rev (3m)-61.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.16%
Revenue NY rev (3m)-5.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 52.08 | ||
| Fwd PE | 13.34 | ||
| P/S | 0.28 | ||
| P/FCF | 4.98 | ||
| P/OCF | 2.39 | ||
| P/B | 0.56 | ||
| P/tB | 5.56 | ||
| EV/EBITDA | 5.29 |
EPS(TTM)0.12
EY1.92%
EPS(NY)0.47
Fwd EY7.5%
FCF(TTM)1.25
FCFY20.07%
OCF(TTM)2.62
OCFY41.91%
SpS22.59
BVpS11.24
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.44% | ||
| ROE | 1.11% | ||
| ROCE | 9.14% | ||
| ROIC | 6.78% | ||
| ROICexc | 7.02% | ||
| ROICexgc | 15% | ||
| OM | 7.98% | ||
| PM (TTM) | 0.55% | ||
| GM | 29.23% | ||
| FCFM | 5.55% |
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ROICexc(3y)4.61%
ROICexc(5y)4.96%
ROICexgc(3y)9.94%
ROICexgc(5y)12.9%
ROCE(3y)5.92%
ROCE(5y)5.98%
ROICexcg growth 3Y14.1%
ROICexcg growth 5Y2.75%
ROICexc growth 3Y23.18%
ROICexc growth 5Y5.84%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
F-Score6
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 6.97 | ||
| Debt/EBITDA | 3 | ||
| Cap/Depr | 151.69% | ||
| Cap/Sales | 6.04% | ||
| Interest Coverage | 3.95 | ||
| Cash Conversion | 96.9% | ||
| Profit Quality | 1002.91% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 1.28 |
F-Score6
WACC5.47%
ROIC/WACC1.24
Cap/Depr(3y)125.61%
Cap/Depr(5y)112.58%
Cap/Sales(3y)5.05%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
EPS Next Y-57.18%
EPS Next 2Y-2.66%
EPS Next 3Y0.8%
EPS Next 5Y8.84%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%
Revenue Next Year-2.14%
Revenue Next 2Y0.08%
Revenue Next 3Y0.85%
Revenue Next 5Y1.97%
EBIT growth 1Y43.9%
EBIT growth 3Y19.21%
EBIT growth 5Y0.28%
EBIT Next Year70.46%
EBIT Next 3Y24.76%
EBIT Next 5Y17.44%
FCF growth 1Y61.15%
FCF growth 3Y11.86%
FCF growth 5Y-5.23%
OCF growth 1Y34.31%
OCF growth 3Y18.3%
OCF growth 5Y-2.03%